Budur Kumar
CHIEF MEDICAL OFFICER
Budur Kumar has filed 4 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Budur Kumar is listed as CHIEF MEDICAL OFFICER at Harmony Biosciences Holdings, Inc. Inside the rolling window, Budur Kumar reported no open-market purchases and 5 open-market sales totaling $3.1M in HRMY. The largest disclosed transaction in the window is a sale of 35,852 HRMY shares on Sep 18, 2026, worth $1.5M.
Companies traded
Other insiders at HRMY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.1M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Budur Kumar made?
Budur Kumar has filed 4 SEC Form 4 filings (21 transaction rows) across 1 company since 2026.
Which companies does Budur Kumar trade?
Budur Kumar has filed SEC Form 4 disclosures for 1 company, including HRMY.
When was Budur Kumar's most recent SEC Form 4 filing?
Budur Kumar's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Budur Kumar's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Budur Kumar is listed as CHIEF MEDICAL OFFICER.
What is Budur Kumar's total buy and sell value in the current window?
Inside the rolling retention window, Budur Kumar bought $0 and sold $3.1M based on SEC Form 4 filings.
What was Budur Kumar's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 35,852 HRMY shares on 2026-09-18, worth $1.5M, per SEC Form 4 filings.